查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1866941

足下垂植入市場按類型、應用和最終用戶分類 - 全球預測 2025-2032

Foot Drop Implants Market by Type, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，足下垂植入市場將成長至 73.4 億美元，複合年成長率為 6.69%。

關鍵市場統計數據
基準年 2024 43.7億美元
預計年份：2025年 46.6億美元
預測年份 2032 73.4億美元
複合年成長率 (%) 6.69%

對臨床需求、技術進步和治療重點進行綜合概述，這些因素共同塑造了現代持久性足下垂矯正方法。

足下垂仍然是神經科、整形外科和復健科領域持續存在的臨床挑戰，而植入式解決方案的進步正在重塑治療路徑。背屈無力的患者面臨活動能力下降、跌倒風險增加以及生活品質的一系列負面影響，因此臨床治療的重點在於恢復功能，而不僅僅是補償功能障礙。過去十年，微創技術、精密的外科手術以及改進的神經刺激設備的融合，為持續的功能恢復創造了新的選擇。

臨床醫生和設備研發人員正在努力解決一個公認的治療缺口。許多保守治療方法只能提供暫時緩解，但不足以達到長期功能恢復；而傳統的外科手術方法創傷性大，且術後復健負擔沉重。在這些情況下，植入式神經刺激設備和肌腱轉移植入因其能夠提供持續的背屈支撐，同時減少日常管理需求，而備受臨床關注。更重要的是，植入式脈衝產生器、電池技術和電極材料的不斷改進，使得植入式設備尺寸更小、刺激更靈敏，並可根據個體步態模式進行客製化。

因此，臨床實踐、研發和醫療設備開發領域的相關人員正在重新調整優先事項，轉向整合植入性能、復健通訊協定和遠端監測的解決方案。本文為深入分析技術成熟度、臨床路徑和醫療保健系統動態如何共同影響足下垂植入領域的採用趨勢和投資決策奠定了基礎。

技術小型化、數位化整合和不斷發展的臨床證據如何重新定義足下垂植入的競爭格局和應用路徑

足下垂植入正經歷一場變革，其驅動力包括技術小型化、新型刺激模式以及個人化復健通訊協定日益成長的重要性。植入式脈衝產生器架構和電極設計的創新，以及精湛的外科手術技術，正在降低手術的複雜性，並擴大以往僅依賴矯正器具的患者群體。同時，包括穿戴式步態分析和遠距復健平台在內的數位健康整合，實現了對治療效果的持續監測，支援設備的迭代最佳化，並能快速識別無反應者。

伴隨這些變化而來的是日益成熟的臨床證據基礎。前瞻性隊列研究和器械註冊登記正開始提供更一致的功能性結果指標。因此，支付者和採購人員開始評估短期改善以外的價值，並優先考慮那些能夠持續改善活動能力並減少後續護理需求的干涉措施。監管路徑也隨著神經刺激技術的創新而不斷發展，明確了對安全性、生物相容性和長期性能指標的預期，從而降低了開發人員和投資者的不確定性。

此外，該行業正經歷競爭格局的重組，成熟的神經調控設備製造商在其產品組合中增加了專門針對足下垂的植入，而專注於特定臨床領域和新型刺激方式的Start-Ups則致力於開發新的刺激模式。這些協同因素正在加速從保守治療到主動器材輔助的背屈功能恢復的轉變，並為外科醫生、復健醫師、工程師和醫療系統領導者之間的跨學科合作創造了新的機會。

評估關稅變化對供應鏈帶來的壓力，並考慮採取策略性應對措施，以增強足下垂植入價值鏈的製造韌性、採購時機和定價機制。

美國關稅調整的累積影響正對足下垂植入生態系統產生多方面衝擊，影響供應鏈策略、零件採購和商業性定價，但並未改變這些先進干預措施的臨床原理。關稅相關的成本壓力對依賴進口專用材料和子組件的設備零件尤其顯著，促使製造商重新評估其籌資策略，並透過近岸外包和選擇替代供應商來降低風險。由於決策者希望確保整體擁有成本和維護成本的確定性，這可能會導致醫院和復健中心的採購週期延長。

為應對這些壓力，製造商正透過重新評估材料清單、最佳化生產佈局以及更加重視可製造性設計，來降低對受關稅影響零件的依賴。此外，他們越來越重視彈性價格設定模式和基本契約的日益複雜也推動了某些領域的垂直整合，尤其是在特殊脈衝產生器和電極系統領域，因為在這些領域，零件的可追溯性對臨床安全至關重要。

整體而言，關稅對營運構成不利影響，促使策略重點轉向供應鏈韌性、製造多元化以及強調可證實的臨床效益的商業結構。對相關人員而言，實際意義在於需要將關稅情境規劃納入採購和產品開發藍圖，以確保能夠持續獲得先進的足下垂治療方案，並保障臨床服務的連續性。

深度細分分析揭示了設備分類、臨床應用和細粒度的最終用戶路徑如何決定其採納、證據需求和商業化策略。

詳細的市場區隔分析揭示了治療需求、設備架構和護理環境如何相互作用，從而影響足下垂植入的商業性和臨床策略。按類型分類，市場分為神經刺激設備植入和肌腱移植植入。神經刺激設備又細分為植入式脈衝產生器和神經電極，其中植入式脈衝產生器又分為不可充電式和可充電式。肌腱移植植入也類似地分為同種異體移植和自體移植。這種細分錶明，耐用性、可充電性和電極介面設計之間的技術權衡直接影響患者選擇和手術流程。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 用於個人化步態矯正的封閉回路型神經刺激系統取得進展
  • 提高足下垂植入中無線充電和遙測技術的整合度
  • 開發用於植入功能性電刺激裝置的微創手術技術
  • 人工智慧驅動的步態分析平台的出現，為最佳化植入程式設計提供了可能。
  • 重點研究發生物相容性電極材料，以提高植入的長期耐久性。
  • 機器人輔助復健與植入式功能刺激裝置的整合
  • 神經調控植入監管核准和報銷框架的演變
  • 利用3D列印技術，透過針對患者特異性的植入設計，提升解剖結構的貼合度。
  • 醫療設備製造商與軟體公司合作，拓展遠端監控能力
  • 穿戴式電療設備的應用日益普及，以補充植入式解決方案。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：足下垂植入市場（按類型分類）

  • 神經刺激設備植入
    • 植入式脈衝產生器
      • 不可充電發電機
      • 可充電發電機
    • 神經電極
  • 肌腱轉移植入
    • 同種異體移植
    • 自體移植

9. 按應用分類的足下垂植入市場

  • 足部麻痺
  • 多發性硬化症
  • 中風後康復
    • 急性中風後
    • 慢性中風後遺症
  • 創傷性神經損傷

第10章 依最終用戶分類的足下垂植入市場

  • 醫院
    • 私立醫院
    • 公立醫院
  • 復健中心
    • 住院復健
    • 門診復健
  • 專科診所

第11章：足下垂植入市場區域分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章：足下垂植入市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 各國足下垂植入市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Ottobock SE & Co. KGaA
    • Bioness, Inc.
    • Innovative Neurotronics, Inc.
    • Ossur hf.
    • NeuroMetrix, Inc.
    • AxioBionics, LLC
    • Stimwave Technologies, Inc.
Product Code: MRR-CD5A9334D49B

The Foot Drop Implants Market is projected to grow by USD 7.34 billion at a CAGR of 6.69% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.37 billion
Estimated Year [2025] USD 4.66 billion
Forecast Year [2032] USD 7.34 billion
CAGR (%) 6.69%

An integrative overview of clinical needs, technological evolution, and therapeutic priorities shaping modern approaches to durable foot drop correction

Foot drop represents a persistent clinical challenge that spans neurology, orthopedics, and rehabilitation disciplines, and advances in implantable solutions are reshaping therapeutic pathways. Patients experiencing dorsiflexion weakness encounter reduced mobility, increased fall risk, and cascading impacts on quality of life, which has focused clinical attention on interventions that restore function rather than merely compensating for deficits. Over the past decade, minimally invasive techniques, refined surgical approaches, and improvements in neurostimulation hardware have converged to create new options for durable functional restoration.

Clinicians and device developers are responding to clearly identified therapy gaps: many conservative measures provide temporary benefit but insufficient long-term functional recovery, while older surgical techniques can be invasive and carry extended rehabilitation burdens. In this context, implantable nerve stimulators and tendon transfer implants are drawing clinical interest for their potential to deliver consistent dorsiflexion support with fewer daily management requirements. Importantly, ongoing iterations in implantable pulse generators, battery technology, and electrode materials are enabling smaller form factors and more nuanced stimulation profiles, which can be tuned to individual gait patterns.

As a result, stakeholders across clinical practice, research, and medical device development are recalibrating priorities toward integrated solutions that couple implant performance with rehabilitation protocols and remote monitoring. This introduction sets the stage for a deeper analysis of how technological maturity, clinical pathways, and health system dynamics combine to influence adoption trends and investment decisions in the foot drop implant space.

How technological miniaturization, digital integration, and evolving clinical evidence are collectively redefining competitive dynamics and adoption pathways for foot drop implants

The landscape for foot drop implants is undergoing transformative shifts driven by technological miniaturization, novel stimulation paradigms, and an increased emphasis on personalized rehabilitation protocols. Innovations in implantable pulse generator architecture and electrode design, coupled with refined surgical techniques, are reducing procedural complexity and expanding candidacy among patients who previously relied solely on orthotic devices. At the same time, digital health integration - including wearable gait analytics and tele-rehabilitation platforms - is enabling continuous outcome monitoring, which supports iterative device optimization and more rapid identification of non-responders.

These changes are accompanied by a maturation of clinical evidence, where prospective cohort studies and device registries are starting to deliver more consistent functional outcome metrics. Consequently, payers and procurement leaders are beginning to assess value beyond short-term improvements, prioritizing interventions that demonstrate durable gains in mobility and reduced downstream care needs. Regulatory pathways are also evolving to accommodate neurostimulation innovations, with clearer expectations around safety, biocompatibility, and long-term performance metrics, which reduces uncertainty for developers and investors.

Furthermore, the industry is witnessing a reconfiguration of competitive dynamics: established neuromodulation device manufacturers are enhancing portfolios to include foot drop-specific implants, while specialized startups are pursuing focused clinical niches and novel stimulation modalities. These converging drivers are accelerating a transition from conservative management toward active, device-mediated restoration of dorsiflexion, and are creating new opportunities for cross-disciplinary collaboration among surgeons, physiatrists, engineers, and health system leaders.

Assessing tariff-driven supply chain pressures and strategic responses that shape manufacturing resilience, procurement timing, and pricing mechanisms across the foot drop implant value chain

The cumulative effect of tariff shifts in the United States on the foot drop implant ecosystem is multifaceted, influencing supply chain strategies, component sourcing, and commercial pricing without altering the clinical rationale for advanced interventions. Tariff-related cost pressures tend to be most acute for device components that rely on specialized imported materials or subassemblies, prompting manufacturers to reassess sourcing strategies and to explore nearshoring or alternative supplier qualification to mitigate exposure. In turn, procurement cycles at hospitals and rehabilitation centers may lengthen as decision-makers seek greater certainty on total cost of ownership and maintenance expenses.

Manufacturers are responding to these pressures by reexamining bill-of-materials, optimizing production footprints, and increasing emphasis on design for manufacturability to reduce dependency on tariff-exposed inputs. Additionally, companies are placing greater importance on flexible pricing models and value-based contracting that align payment with demonstrated functional improvements, thereby insulating providers from price volatility. Regulatory compliance and customs complexity are also encouraging greater vertical integration in certain segments, particularly for specialized pulse generators and electrode systems where component traceability is critical for clinical safety.

Overall, tariffs introduce an operational headwind that shifts strategic focus toward supply chain resilience, diversified manufacturing, and commercial structures that emphasize demonstrable clinical benefit. For stakeholders, the practical implication is a need to incorporate tariff scenario planning within procurement and product development roadmaps to maintain predictable access to advanced foot drop interventions and to preserve continuity in clinical services.

Deep segmentation analysis revealing how device typologies, clinical applications, and nuanced end-user pathways determine adoption, evidence needs, and commercialization strategies

A nuanced read of segmentation reveals how therapeutic needs, device architecture, and care settings interplay to shape commercial and clinical strategy for foot drop implants. Based on Type, the market is examined across nerve stimulator implants and tendon transfer implants, with nerve stimulators further differentiated into implantable pulse generators and nerve electrodes, and implantable pulse generators further dissected into non-rechargeable and rechargeable generator options; tendon transfer implants are similarly parsed into allograft transfers and autograft transfers. This granularity highlights that engineering trade-offs between longevity, rechargeability, and electrode interface design directly influence patient selection and surgical workflow.

Based on Application, the portfolio of use cases spans foot palsy, multiple sclerosis, post stroke rehabilitation, and traumatic nerve injury, with post stroke rehabilitation further distinguished into acute post stroke and chronic post stroke scenarios. Clinical pathways differ substantially across these applications: acute post stroke interventions prioritize early functional recovery and integration with inpatient rehabilitation, while chronic post stroke and neurodegenerative conditions emphasize long-term management and device programmability. These distinctions drive divergent evidence requirements, where acute settings often necessitate rapid outcome readouts, and chronic conditions require longitudinal performance data to justify continued device use.

Based on End User, adoption patterns vary among hospitals, rehabilitation centers, and specialty clinics, with hospitals parsed into private and public institutions and rehabilitation centers separated into inpatient and outpatient modalities. Hospital-based adoption is influenced by procedural volume, surgical expertise, and capital planning cycles, whereas rehabilitation centers weigh integration with therapy programs and ease of device tuning. Specialty clinics often act as early adopters focused on niche protocols. Understanding this layered segmentation enables stakeholders to align clinical trials, reimbursement strategies, and go-to-market activities with the distinct needs and operational realities of each segment.

How regional regulatory diversity, reimbursement expectations, and clinical infrastructure shape differentiated commercialization pathways for foot drop implant technologies

Regional dynamics exert a decisive influence on regulatory interpretation, clinical practice variability, and supply chain logistics for foot drop implants. In the Americas, clinical adoption has been shaped by a mix of advanced neuromodulation centers, integrated healthcare systems, and a concentrated set of referral pathways that facilitate device testing within multidisciplinary teams. Reimbursement frameworks and hospital procurement processes in this region tend to emphasize demonstrable functional outcomes and cost-consequence narratives, which in turn shapes evidence generation and post-market surveillance strategies.

In Europe, Middle East & Africa, regulatory diversity and heterogeneous payer structures create both opportunities and challenges for manufacturers; high-performing centers in metropolitan areas often act as hubs for early clinical adoption and device refinement, while broader geographic variability demands flexible distribution and training models. Stakeholders operating in this region frequently adopt centralized regulatory strategies combined with localized clinical education to ensure consistent surgical standards and patient follow-up.

In the Asia-Pacific region, the growth of specialized rehabilitation infrastructure, investments in medical technology manufacturing, and a growing emphasis on outcomes-based care are driving interest in implantable interventions. However, differing regulatory timelines, surgical training availability, and variable hospital procurement mechanisms require manufacturers to calibrate market entry plans carefully. Across all regions, successful commercialization depends on tailored clinical evidence packages, robust training programs for surgical and rehabilitation teams, and adaptable supply chain arrangements that respect regional regulatory and reimbursement nuances.

Competitive landscape dynamics driven by platform modularity, clinical partnerships, and real-world evidence strategies that determine differentiation and long-term market viability

Competitive dynamics in the foot drop implant space reflect a combination of established neuromodulation expertise and focused clinical innovators, producing an ecosystem where strategic partnerships and platform extensibility matter as much as device performance. Leading device developers prioritize modular architectures that support both implantable pulse generators and electrode interfaces, enabling rapid iteration and clinical customization while maintaining a common software and service layer for programming and remote monitoring. This modular approach reduces time-to-market for incremental improvements and facilitates managed care conversations around long-term outcomes and service contracts.

At the same time, specialized clinical innovators concentrate on surgical technique optimization and patient phenotyping to demonstrate superior functional outcomes in targeted cohorts, partnering with rehabilitation providers to integrate stimulation protocols into comprehensive care pathways. Supply chain partners and contract manufacturers that can deliver medical-grade components with high traceability are increasingly strategic, particularly where regulatory expectations include rigorous long-term safety documentation. Across the competitive landscape, successful companies invest in evidence generation through registries and real-world data collection, and they build scalable training programs to lower the barrier to clinical adoption.

Finally, collaborations between device manufacturers, rehabilitation technology firms, and digital health platforms are becoming a competitive differentiator, as integration of wearable gait analytics and clinician dashboards enables continuous therapeutic tuning and supports value-based contracting conversations with providers and payers. For investors and corporate strategists, the interplay between platform flexibility, clinical partnerships, and data-driven care models will determine long-term viability and differentiation.

Actionable strategic priorities for product design, evidence generation, supply chain resilience, clinician training, and outcomes-based commercial models to accelerate adoption

Industry leaders seeking to accelerate adoption and commercial success for foot drop implants should align product development with clear clinical workflows and payer expectations while strengthening supply chain resilience. Prioritize device designs that balance rechargeability and longevity with surgical simplicity, and ensure electrode interfaces support adjustable stimulation profiles that can be personalized to patient gait. Concurrently, invest in pragmatic clinical studies and real-world registries that capture meaningful functional outcomes across acute and chronic care settings to support reimbursement discussions and hospital procurement committees.

Operationally, manufacturers should pursue supplier diversification and consider nearshoring critical component production where tariff exposure or customs complexity presents material risk. Develop comprehensive training and certification programs for surgeons and rehabilitation clinicians to reduce variability in implantation and programming, and build integrated care pathways that align implant intervention with targeted therapy regimens to maximize functional gains. Moreover, establish partnerships with digital health providers to incorporate wearable gait analytics and remote monitoring into product offerings, thereby creating differentiated services that support outcomes-based contracting.

From a commercial standpoint, tailor market entry approaches by region and end-user type, emphasizing solutions that demonstrate clear operational benefits in the specific care setting, whether that is inpatient stroke units, outpatient rehab clinics, or specialty centers. Finally, maintain a flexible pricing architecture that can accommodate device lifecycle models, service subscriptions, and bundled care agreements to meet the diverse financial constraints of private and public health systems.

A transparent multi-method research approach combining clinician interviews, regulatory review, literature synthesis, and supply chain scenario analysis to validate findings and recommendations

The research underpinning this analysis combined a multi-method approach designed to integrate clinical, regulatory, and commercial perspectives while ensuring transparency and reproducibility. Primary inputs included structured interviews with surgeons, physiatrists, rehabilitation therapists, and procurement leaders, along with consultations with device engineers and quality/regulatory experts to validate technical feasibility and safety considerations. Secondary inputs comprised peer-reviewed clinical literature, device-specific regulatory filings, standards documentation on implantable neuromodulation safety, and public clinical trial registries to corroborate outcome measures and study designs.

Data synthesis involved cross-validation of qualitative insights against documented clinical outcomes and regulatory frameworks, with an emphasis on triangulating evidence where limited randomized data exists. The methodology also incorporated scenario analysis for supply chain and tariff impacts, mapping dependencies across bill-of-materials, manufacturing geographies, and distribution channels to surface operational vulnerabilities and viable mitigation strategies. Peer review of the findings was conducted by external clinical advisors to ensure clinical plausibility and to refine recommendations related to care pathways and training requirements.

All sources were cataloged and assessed for methodological rigor and relevance, and where gaps were identified, targeted primary interviews were executed to fill critical knowledge voids. This approach produced a consolidated, practice-oriented perspective on the technology, clinical adoption barriers, and commercial levers that inform the strategic guidance presented in the report.

A conclusive synthesis emphasizing the clinical promise, operational imperatives, and cross-disciplinary actions required to convert technological advances into durable patient mobility improvements

In conclusion, foot drop implants represent a maturing intersection of neuromodulation engineering, surgical innovation, and rehabilitation science that collectively offers the potential to transform mobility outcomes for patients with diverse neurologic etiologies. The trajectory of the field is shaped by technology choices around pulse generator architecture and electrode design, the quality and scope of clinical evidence across acute and chronic applications, and pragmatic considerations tied to regional regulatory and reimbursement environments. Stakeholders who align product design with care pathways, invest in evidence generation, and cultivate durable clinical partnerships will be best positioned to deliver meaningful patient benefit and to navigate commercial complexities.

Operational resilience, including proactive supply chain strategies and flexible commercialization models, will mitigate external headwinds such as tariff-related cost pressures while preserving timely access to advanced devices. Moreover, the integration of digital monitoring and data-driven rehabilitation protocols will increasingly drive differentiation and enable value-based conversations with payers and providers. As the field evolves, a focus on patient-centered outcomes, standardized measurement frameworks, and scalable clinician training will be essential to translate technological promise into measurable improvements in mobility and quality of life.

The cumulative picture is one of cautious optimism: opportunities for clinical impact and commercial growth exist, but realizing them requires coordinated effort across engineering, clinical research, and health system stakeholders to ensure that innovations are both effective and deliverable within real-world care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Advancements in closed loop neurostimulation systems for personalized gait correction
  • 5.2. Increase in wireless charging and telemetry integration for foot drop implants
  • 5.3. Development of minimally invasive surgical techniques for implanting FES devices
  • 5.4. Emergence of AI driven gait analysis platforms for optimized implant programming
  • 5.5. Focus on biocompatible electrode materials to enhance long term implant durability
  • 5.6. Integration of robotics assisted rehabilitation with implanted functional stimulators
  • 5.7. Regulatory approvals and reimbursement frameworks evolving for neuromodulation implants
  • 5.8. Patient specific implant designs using 3D printing for improved anatomical fit
  • 5.9. Collaborations between medtech and software companies to expand remote monitoring capabilities
  • 5.10. Increasing prevalence of wearable electroceutical devices complementing implanted solutions

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Foot Drop Implants Market, by Type

  • 8.1. Nerve Stimulator Implants
    • 8.1.1. Implantable Pulse Generators
      • 8.1.1.1. Non Rechargeable Generators
      • 8.1.1.2. Rechargeable Generators
    • 8.1.2. Nerve Electrodes
  • 8.2. Tendon Transfer Implants
    • 8.2.1. Allograft Transfers
    • 8.2.2. Autograft Transfers

9. Foot Drop Implants Market, by Application

  • 9.1. Foot Palsy
  • 9.2. Multiple Sclerosis
  • 9.3. Post Stroke Rehabilitation
    • 9.3.1. Acute Post Stroke
    • 9.3.2. Chronic Post Stroke
  • 9.4. Traumatic Nerve Injury

10. Foot Drop Implants Market, by End User

  • 10.1. Hospitals
    • 10.1.1. Private Hospitals
    • 10.1.2. Public Hospitals
  • 10.2. Rehabilitation Centers
    • 10.2.1. Inpatient Rehabilitation
    • 10.2.2. Outpatient Rehabilitation
  • 10.3. Specialty Clinics

11. Foot Drop Implants Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Foot Drop Implants Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Foot Drop Implants Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. Ottobock SE & Co. KGaA
    • 14.3.2. Bioness, Inc.
    • 14.3.3. Innovative Neurotronics, Inc.
    • 14.3.4. Ossur hf.
    • 14.3.5. NeuroMetrix, Inc.
    • 14.3.6. AxioBionics, LLC
    • 14.3.7. Stimwave Technologies, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. FOOT DROP IMPLANTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. FOOT DROP IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. FOOT DROP IMPLANTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NON RECHARGEABLE GENERATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NON RECHARGEABLE GENERATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NON RECHARGEABLE GENERATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NON RECHARGEABLE GENERATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NON RECHARGEABLE GENERATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NON RECHARGEABLE GENERATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY RECHARGEABLE GENERATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY RECHARGEABLE GENERATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY RECHARGEABLE GENERATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY RECHARGEABLE GENERATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY RECHARGEABLE GENERATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY RECHARGEABLE GENERATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE ELECTRODES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE ELECTRODES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE ELECTRODES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE ELECTRODES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE ELECTRODES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE ELECTRODES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY ALLOGRAFT TRANSFERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY ALLOGRAFT TRANSFERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY ALLOGRAFT TRANSFERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY ALLOGRAFT TRANSFERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY ALLOGRAFT TRANSFERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY ALLOGRAFT TRANSFERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY AUTOGRAFT TRANSFERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY AUTOGRAFT TRANSFERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY AUTOGRAFT TRANSFERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY AUTOGRAFT TRANSFERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY AUTOGRAFT TRANSFERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY AUTOGRAFT TRANSFERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY FOOT PALSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY FOOT PALSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY FOOT PALSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY FOOT PALSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY FOOT PALSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY FOOT PALSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY ACUTE POST STROKE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY ACUTE POST STROKE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY ACUTE POST STROKE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY ACUTE POST STROKE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY ACUTE POST STROKE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY ACUTE POST STROKE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY CHRONIC POST STROKE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY CHRONIC POST STROKE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY CHRONIC POST STROKE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY CHRONIC POST STROKE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY CHRONIC POST STROKE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY CHRONIC POST STROKE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TRAUMATIC NERVE INJURY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TRAUMATIC NERVE INJURY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TRAUMATIC NERVE INJURY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TRAUMATIC NERVE INJURY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TRAUMATIC NERVE INJURY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TRAUMATIC NERVE INJURY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY INPATIENT REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY INPATIENT REHABILITATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY INPATIENT REHABILITATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY INPATIENT REHABILITATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY INPATIENT REHABILITATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY INPATIENT REHABILITATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY OUTPATIENT REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY OUTPATIENT REHABILITATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY OUTPATIENT REHABILITATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY OUTPATIENT REHABILITATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY OUTPATIENT REHABILITATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY OUTPATIENT REHABILITATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 256. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2018-2024 (USD MILLION)
  • TABLE 258. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2025-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 260. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2025-2032 (USD MILLION)
  • TABLE 271. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 276. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 277. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2018-2024 (USD MILLION)
  • TABLE 278. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2025-2032 (USD MILLION)
  • TABLE 279. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 280. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 281. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 282. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 283. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 284. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2025-2032 (USD MILLION)
  • TABLE 285. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 288. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 289. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2018-2024 (USD MILLION)
  • TABLE 290. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2025-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 296. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2018-2024 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2025-2032 (USD MILLION)
  • TABLE 299. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 300. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 301. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 304. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2025-2032 (USD MILLION)
  • TABLE 305. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 306. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 307. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 308. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 309. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2018-2024 (USD MILLION)
  • TABLE 310. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2025-2032 (USD MILLION)
  • TABLE 311. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 312. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 313. ASEAN FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. ASEAN FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. ASEAN FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. ASEAN FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. ASEAN FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR